Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

Why might that be? “Maximum concentration of semaglutide is reached 1 to 3 days post dose.” That bit of pharmacokinetics comes from Ozempic’s package insert. The half-life of natural (endogenous) ...